Back to results
US 2020/0368153 A1Published application
Eye drop formulation and method for sustained delivery of medicament to the retina
AssigneeIdrop , Inc.
InventorsVernon G. Wong, Glenn T. Huang
Life of this patent
Estimating the term…
Abstract
The present embodiments provide compositions, methods and kits for the treatment of ocular conditions or maladies affecting the back of the eye, e.g., the retina.
Claims23
A liquid depot for sustained release of an active agent to the back of the eye, the liquid depot comprising:
- a tocopherol;
- an ocular film-forming excipient;
- and an active agent;
- wherein the liquid depot has a viscosity of about 850 cP to about 1100 cP, inclusive.
1 more element
-23. (canceled)
A method of treating the retina in an eye of a subject, comprising topically administering to the eye of the subject a liquid depot comprising, consisting, or consisting essentially of (a) about 10%-30% (wt %) dexamethasone;
- and (b) about 70%-90% (wt %) of a mixture of tocopheryl acetate:medium-chain triglycerides at a wt/wt ratio of about 85:15 to about 70:30.
-31. (canceled)
Dependencies are inferred from the claim text.